18-50227413-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_145020.5(CFAP53):c.1513C>A(p.Arg505Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000527 in 1,614,050 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R505C) has been classified as Likely benign.
Frequency
Consequence
NM_145020.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFAP53 | NM_145020.5 | c.1513C>A | p.Arg505Ser | missense_variant | 8/8 | ENST00000398545.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFAP53 | ENST00000398545.5 | c.1513C>A | p.Arg505Ser | missense_variant | 8/8 | 1 | NM_145020.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000361 AC: 55AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000309 AC: 77AN: 249468Hom.: 0 AF XY: 0.000296 AC XY: 40AN XY: 135352
GnomAD4 exome AF: 0.000545 AC: 796AN: 1461724Hom.: 1 Cov.: 30 AF XY: 0.000518 AC XY: 377AN XY: 727144
GnomAD4 genome ? AF: 0.000361 AC: 55AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74498
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2023 | The c.1513C>A (p.R505S) alteration is located in exon 8 (coding exon 8) of the CCDC11 gene. This alteration results from a C to A substitution at nucleotide position 1513, causing the arginine (R) at amino acid position 505 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Heterotaxy, visceral, 6, autosomal Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jan 12, 2022 | This variant is present in population databases (rs192619553, gnomAD 0.06%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). This variant has not been reported in the literature in individuals affected with CFAP53-related conditions. This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 505 of the CFAP53 protein (p.Arg505Ser). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at